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Abstract
Acinetobacter baumannii is nowadays a relevant nosocomial pathogen characterized by multidrug resistance (MDR) and con-
comitant difficulties to treat infections. OmpA is the most abundant A. baumannii outer membrane (OM) protein, and is involved 
in virulence, host- cell recognition, biofilm formation, regulation of OM stability, permeability and antibiotic resistance. OmpA 
members are two‐domain proteins with an N‐terminal eight‐stranded β‐barrel domain with four external loops (ELs) interact-
ing with the environment, and a C‐terminal periplasmic domain binding non‐covalently to the peptidoglycan. Here, we combined 
data from genome sequencing, phylogenetic and multilocus sequence analyses from 975 strains/isolates of the Acinetobacter 
calcoaceticus/Acinetobacter baumannii complex (ACB), 946 from A. baumannii, to explore ompA microevolutionary divergence. 
Five major ompA variant groups were identified (V1 to V5) in A. baumannii, encompassing 52 different alleles coding for 23 
different proteins. Polymorphisms were concentrated in five regions corresponding to the four ELs and the C‐terminal end, 
and provided evidence for intra‐genic recombination. ompA variants were not randomly distributed across the A. baumannii 
phylogeny, with the most frequent V1(lct)a1 allele found in most clonal complex 2 (CC2) strains and the second most frequent 
V2(lct)a1 allele in the majority of CC1 strains. Evidence was found for assortative exchanges of ompA alleles not only between 
separate A. baumannii lineages, but also different ACB species. The overall results have implications for A. baumannii evolution, 
epidemiology, virulence and vaccine design.
DATA SummARy
All of the data in this study was downloaded from public 
databases. A complete list of the GenBank assembly acces-
sion numbers, or PubMLST id numbers, for all of the 
Acinetobacter genome sequences used in this study are given 
in Table S6 (available in the online version of this article). 
Accession numbers for other bacterial species are provided in 
Table S5. Accession numbers for specific contigs containing 
ompA alleles are given in Table S1, and accession numbers for 
non‐A. baumannii Acinetobacter genomes containing specific 
ompA alleles are given in Table S2.
InTRoDuCTIon
The genus Acinetobacter (family Moraxellaceae, class 
Gammaproteobacteria) is composed of Gram‐negative bacte-
rial organisms of ubiquitous environmental distribution [1]. It 
includes a number of phylogenetically closely related species 
generally associated with the human environment grouped 
into the so‐called Acinetobacter calcoaceticus/Acinetobacter 
baumannii complex (ACB). Of these, A. baumannii represents 
the most problematic nosocomial species generally affecting 
critically ill patients [1–7]. Molecular- typing studies have indi-
cated that infective A. baumannii strains belong to a limited 
number of globally distributed clonal groups/complexes 
(CCs) estimated to have emerged and disseminated after 1960, 
and from which CC2 and CC1 have been the most thoroughly 
characterized [2–5, 7–10]. The reasons for the success of CC 
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strains as human pathogens are still poorly understood, but 
are thought to include the general resilience of the species, an 
increased ability to colonize the human environment, and the 
propensity to acquire exogenous genetic material [2–7, 10]. 
Thus, most CC strains not only show multi‐drug resistance 
(MDR) phenotypes from the acquisition of different mobile 
genetic elements enriched in resistance genes, but can also 
rapidly modify virulence‐related surface structures recog-
nized by host defenses as the result of recombination events 
involving discrete genomic loci [2–5, 7, 10–13]. This has left 
very few treatment options available [2–5, 7, 11, 14, 15] and 
has led to the alternative search of targets for anti‐virulence 
drugs or vaccines, and in this context a potential candidate 
is represented by the major A. baumannii outer membrane 
(OM) protein, OmpA [5, 6, 16–24]. A. baumannii OmpA 
belongs to the widely distributed OmpA/OprF family of OM 
proteins from which Escherichia coli OmpA and Pseudomonas 
OprF are well‐characterized examples [25–27]. These proteins 
are structured in two domains: an N‐terminal eight‐stranded 
β‐barrel embedded in the OM exposing four loops to the 
environment (ELs), and a C‐terminal periplasmic domain 
that binds the peptidoglycan and contributes to cell- envelope 
stability [26–28]. E. coli OmpA ELs play important roles in 
target- cell recognition and bacterial survival once internal-
ized, and variations in EL2 and EL3 composition or length 
affect the invasive potential of the bacterial cells [26]. Given 
the many interactions of ELs with environmental factors, it is 
not surprising that they represent the less conserved protein 
regions with both mutation and recombination providing for 
the observed variabilities [25–27, 29]. A. baumannii OmpA 
has been implicated in a multitude of functions that range 
from structural roles, a slow porin for small hydrophilic nutri-
ents and antimicrobials, and virulence including fibronectin 
binding, biofilm formation, adhesion to host cells and cyto-
toxicity [3, 5, 6, 20, 21, 27, 29–37]. It has also been shown 
to interact with host defenses, inducing innate immune 
responses, the production of antibodies both in A. baumannii‐
infected patients and experimentally infected mice, and to 
bind antimicrobial peptides via the ELs [17–24, 38]. It follows 
that there are different selective pressures including trade‐off 
mechanisms [26, 27, 39–43] acting on A. baumannii OmpA. 
However, to our knowledge no systematic studies have been 
conducted on A. baumannii OmpA microevolution. Here, we 
analysed the polymorphism of A. baumannii OmpA and the 
roles of mutation and recombination in defining this vari-
ability, to analyze the extent to which selection in the clinical 
setting has shaped this protein.
mETHoDS
Sequence retrieval, alignments and phylogeny 
estimations
The nucleotide sequence of ompA from A. baumannii 
ACICU (accession number NC_017162.1, locus tag 
ABK1_RS15935) was used to query the JGI SIMG/M 
database (https:// img. jgi. doe. gov/) for available ompA 
sequences from A. baumannii genomes. ompA nucleotide 
sequences obtained by this procedure were translated, 
aligned, separated into five groups of similarity on the 
basis of a maximum‐likelihood (ML) phylogenetic analysis 
(Fig. 1, see below). A representative sequence from each 
group was used as a query to search for homologous ompA 
sequences in the strains/isolates present in the A. baumannii 
MLST (Pasteur) database (updated 14 January 2020; 1256 
sequences) from which whole- genome sequence data were 
additionally available (https:// pubmlst. org/ bigsdb? db= 
pubmlst_ abaumannii_ pasteur_ seqdef). The blastn data 
analysis plugin tool provided in the database was used for 
this purpose. ompA sequences identified in each of the 
strains/isolates were then extracted using the tools also 
provided in the database, and assigned to a given variant/
allele group. The sequence identification numbers (Seqbin 
id#:) as well as the nucleotide initiation and termination 
numbers covered by the corresponding ompA sequences 
extracted using MLST database tools are provided for 
each strain/isolate in Table S1. For a small number of 
Impact Statement
Acinetobacter baumannii is an increasing MDR threat in 
nosocomial settings associated with prolonged hospi-
talization and concomitantly increased healthcare costs. 
The main A. baumannii OM protein, OmpA, is a multifac-
eted two‐domain protein implicated in host- cell recog-
nition and adhesion, cytotoxicity, biofilm formation and 
as a slow porin for antibiotics and small hydrophilic 
nutrients. A. baumannii OmpA has been proposed as a 
potential target for anti‐virulence drugs and as a vaccine 
candidate. Given the many interactions of this protein 
with environmental factors including host defenses, it is 
certainly subjected to many selective pressures. Here, 
we analysed the microevolution of this OM protein in the 
A. baumannii population to obtain clues on the extent to 
which selection in the clinical setting has shaped this 
protein. The results provide relevant information on the 
main causes driving evolution of this protein, with poten-
tial implications in A. baumannii epidemiology, virulence 
and vaccine design. Vaccines are being explored as a 
potential new approach to combat bacterial pathogens 
that have become resistant to most or all antibiotics avail-
able to treat them. A. baumannii is one such WHO priority 
pathogen, and OmpA proposed as a vaccine target. Many 
recent studies have investigated the virulence properties 
associated with OmpA and its immunogenicity. However, 
these studies do not take into account the large degree 
of variation in OmpA sequence we describe here, which 
is concentrated in the protein regions that would act as 
antigenic determinants. Therefore, our work illustrates 
the general principle that a detailed understanding of the 
diversity and evolution of proposed antigens is essential 
for the efficient and effective development of vaccines 
against MDR bacterial pathogens.
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Fig. 1. Co‐existence of different OmpA variants and sub‐variants in the A. baumannii population. An unrooted ML phylogenetic tree was 
constructed using PhyML (http://phylogeny.lirmm.fr/phylo_cgi/index.cgi) using alignments of translated ompA sequences representing 
all OmpA protein alleles identified in A. baumannii in this work. The lengths of the branches are proportional to the evolutionary distance, 
with the scale bar (estimated changes per site) shown at the bottom right. Bootstrap support (percentages of 100 re‐samplings) for the 
different clusters are indicated at the corresponding branches. The analysis shows that OmpA proteins found in A. baumannii comprise 
five well‐defined similarity groups of alleles (V1–V5, indicated by ovals) each defining a particular variant. Some variants such as V1 
and V4 in A. baumannii additionally encompass a sub‐variant group identified with the suffix (lct) or (sct) (implying longer C‐terminal 
tract and shorter C‐terminal tract, respectively) that differ between them by the presence/absence of a hydrophobic tract of six amino 
acid residues composed mostly by alanine residues close to the corresponding C‐terminal ends (see the main text for a more detailed 
description). The lengths in amino acid residues of the corresponding variant and sub‐variant OmpA proteins are indicated for each 
variant cluster.
A. baumannii isolates, which received ST assignments but 
lacked genome sequence information in the MLST data-
base, but for which complete genome, scaffolds or contig 
sequences were available from the NCBI database (https://
www. ncbi. nlm. nih. gov/ genome/ genomes/ 403?), ompA 
sequences were extracted from this database using the 
blastn tool and incorporated into the analysis conducted 
here. In these cases the corresponding sequence accession 
numbers and location of the ompA nucleotide sequences are 
also provided in Table S1. Also, for selected A. baumannii 
isolates collected over a 30‐year period (Table S1) and 
characterized as belonging to lineage 1 (L1) of global clone 
1 (GC1) [10], the pertinent housekeeping gene sequences 
were extracted besides the corresponding ompA sequences 
from the sequence data available in the NCBI database. 
In these cases ST assignments were inferred from these 
data following comparisons with the corresponding allele 
sequences of the MLST Pasteur scheme (https:// pubmlst. 
org/ bigsdb? db= pubmlst_ abaumannii_ pasteur_ seqdef& 
page= downloadAlleles). Expectedly, all of these isolates 
belonged to clonal complex 1 (CC1) (see Table S1 for 
details).
A similar procedure to that described above was used to detect 
ompA sequences among 29 strains/isolates of non‐baumannii 
ACB species including A. calcoaceticus, A. lactucae, A. nosoco-
mialis, A. oleivorans, A. pittii and A. seifertii, for which whole- 
genome sequence data were available in the NCBI database 
(https://www. ncbi. nlm. nih. gov/ genome/ genomes/). In these 
cases the corresponding accession numbers and the location 
of the genes in the analysed sequence data are indicated in 
Table S2.
A. baumannii strains/isolates in which incomplete 
ompA sequences resulting from premature termination 
codons, frameshifts, and/or insertions as detected by the 
sequence comparison analyses conducted in this work 
were omitted from the analysis. In the case of redun-
dant isolates, only one was included in the analysis. 
Moreover, in the case of V1 and V2 ompA alleles found in 
A. baumannii (the most abundant sequences found, 
Table S2), nucleotide substitutions found only once 
among all ompA sequences analysed were consid-
ered sequencing errors and the corresponding isolates 
were also omitted from the analysis. This left 946 A. 
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Table 1. Characteristics of the different A. baumannii OmpA variant (V) groups
V group No. of alleles 
(genes/ 
proteins)
















V1(lct) 32/12 723 1071 356 334 QEAAAPAAAQ 76.43 %
V1(sct) 2/2 6 1053 350 328 QQAQ 0.63 %
V2(lct) 6/2 167 1062 353 331 QEAAAPAAAQ 17.63 %
V3(sct) 1/1 20 1029 342 320 QQAQ 2.1 %
V4(lct) 7/4 23 1050 349 327 QEAAAPAAAQ 2.43 %
V4(sct) 2/2 2 1032 343 321 QQAQ 0.21 %
V5(sct) 1/1 5 1044 347 325 QQAQ 0.53 %
baumannii strains/isolates (Tables S1 and S2) analysed in 
this work. Expectedly, the database was biased towards 
A. baumannii clinical isolates of human origin, in particular 
CC2 and CC1 isolates, which encompassed 53 and 7.7 %, 
respectively, of the total sample (Table S1). Information 
provided by the MLST database of an origin other than a 
human source was incorporated into Table S1.
Protein or nucleotide ML phylogenetic trees were constructed 
using PhyML (http:// phylogeny. lirmm. fr/ phylo_ cgi/ index. 
cgi). Assembled Acinetobacter genomes used in this work 
were obtained from the NCBI database as detailed above. 
All genome accession numbers are given in Table S6. A core 
gene alignment was obtained using Roary [44], and the ML 
phylogeny was estimated using FastTree v2.1.10, with support 
estimated from 1000 resamples [45].
Protein sequence diversity
Variation between A. baumannii OmpA variants was deter-
mined by calculating the Shannon entropy from alignments 
of the protein alleles described here (https://www. hiv. gov/ 
content/ sequce/ ENTROPY/ entropy. html), as described 
previously for A. baumannii CarO [11].
Intragenic recombination detection
An alignment containing one of each A. baumannii ompA 
allele was loaded into the Recombination Detection Program 
v4 (RDP4) [46]. An automated recombination analysis was 
run using the RDP [47], GENCONV [48] and Chimera [49] 
methods. Regions in which significant evidence for recombi-
nation was detected were removed using the ‘Save alignment 
with recombinant regions removed’ feature in RDP, and used 
in subsequent analyses.
Tests for selection
To investigate whether natural selection is acting similarly in 
the A. baumannii ompA EL regions as compared to the rest of 
the protein, we used a partition model in the program codeml 
implemented in PAML v4.9d [50, 51]. Separate alignments for 
alleles from groups V1, V2 and V4 either including all data, 
or with recombinant regions removed, were used to estimate 
trees using PhyML, which then had distance information 
manually removed for use as input to codeml. Input align-
ment files were partitioned into sequences corresponding to 
exposed EL regions and those corresponding to non‐exposed 
TM and periplasmic domains. Two models were fitted to the 
data in codeml, a null model where parameter values are 
assumed to be equal between the exposed and non‐exposed 
regions of the sequence (model =0, NSsites=0, Mgene=0), 
and an alternative model where κ (transition/transversion rate 
ratio), ω (dN/dS), πs (codon frequencies) and cs (proportional 
branch lengths) are allowed to vary between the two regions 
(model=0, NSsites=0, Mgene=4). The resulting log likelihood 
values from the two models were compared using χ2 tests to 
determine whether the alternative models better fit the data 
than the null models. V3 and V5 were excluded from this 
analysis as they only contain one allele each in A. baumannii.
RESuLTS
ompA polymorphism in the A. baumannii population
ompA sequences were extracted from 975 genomes of ACB 
strains/isolates deposited in databases, of which 946 were 
A. baumannii (Table S1 and Table S2, see Methods for details). 
A ML phylogeny based upon the alignments of the corre-
sponding translated sequences identified five well‐defined 
OmpA variant groups, hereafter called V1 to V5 (Fig. 1). 
In A. baumannii, each of the identified variant groups was 
composed of a different number of alleles sharing high levels 
of nucleotide sequence identity (>98%) between them (Table 
S2). Between these different variants the protein sequence 
identities ranged from ca. 94 % for V1 and V2 to ca. 85 % 
between them and the most divergent group V3. An unequal 
distribution of ompA variants was found, with almost 95 % 
of the A. baumannii strains/isolates carrying alleles from 
only V1 and V2 (Tables 1 and S2). Also, A. baumannii V1 
and V4 variants each encompassed two sub‐variant groups 
designated V1(lct)/V1(sct) and V4(lct)/V4(sct), respectively 
(Tables 1 and S1, S2, Figs 2, S1 and S2). Each subgroup could 
be distinguished by the presence/absence of a six amino 
acid stretch (AAAPAA) close to the C‐terminal end, thus 
defining QEAAAPAAAQ (longer C- terminal tract- lct) or 
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Fig. 2. Sequence variability between A. baumannii OmpA variants and sub‐variants. (a) Shannon- entropy variation along the amino 
acid alignments of the OmpA variant and sub‐variant representative alleles shown in Fig. 1. The program available at http://www.hiv.
lanl.gov/content/sequence/ENTROPY/entropy.html was used for entropy computations. The heights of the bars are proportional to 
the degree of amino acid variation at a particular location in the alignments. The span of the predicted external loops EL1 to EL4 at 
the N‐terminal domain and the variable C‐terminal motif (VR5) are indicated by closed bars above the figure. Alignments are numbered 
from the corresponding N‐terminal regions including the signal peptide. (b) Amino acid (left columns) and corresponding nucleotide 
alignments (right columns) of the EL regions and the C‐terminal domains of representative ompA variant alleles. The amino acid and 
nucleotide positions encompassing the EL1 to EL4 regions indicated above the sequences are those corresponding to ACICU (V1) OmpA. 
In VR5 the numbers at the end indicate the position of the last amino acid or nucleotide in the corresponding columns, and the high‐GC 
5´‐GCGGCAGCTCCTGCAGCA‐3′ insertion coding for the extra AAAPAA stretch found at the C‐terminus in some variant sequences is 
shown. Uppercase letters in nucleotide alignments indicate the same base at a given position in all sequences. RDP4 detected evidence 
for recombination between V3 and V4 variants at EL1 and between V4 and V5 variants at a gene region encompassing the entire EL3 and 
part of EL4 (highlighted in blue). In addition, visual inspection detected sequence identity between V4 and V5 sequences along the entire 
EL2 (highlighted in blue), as well as between V2 and V4 along the complete EL4 region [highlighted in green for V2 and V4(lct) only]. The 
complete amino acid and nucleotide alignments, as well as the topology predictions, are shown in Figs S1 and S2.
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QQAQ (shorter C‐terminal tract ‐ sct) as alternate C‐terminal 
sequences in the corresponding proteins. The possible origin 
of this stretch is discussed in more detail below.
The OmpA V1(lct) subgroup was by far the most frequently 
observed among the A. baumannii population analysed, with 
76.4 % of all strains/isolates analysed carrying V1(lct) alleles 
(Tables 1 and S2). It encompassed 32 gene alleles differing by 
a maximum of 20 nucleotide substitutions, translated to 12 
different OmpA proteins differing from none to a maximum 
of four amino acid substitutions. Among them, the V1(lct)
a1 allele was predominant, representing more than 66 % of 
all V1 alleles detected and being found in 51 % of the total 
A. baumannii strains/isolates analysed (Table S2). Of note, 
the A. baumannii type strain ATCC 19606 and also the ATCC 
17978 strain, isolated from human clinical materials around 
or before 1950 [52, 53], display V1(lct) alleles [V1(lct)a14 and 
V1(lct)a19, respectively, Table S1]. This dates the association 
of ompA V1(lct) alleles with A. baumannii clinical strains 
prior to the emergence and spread of the main epidemic 
clones, estimated to have occurred in the 1960s [4, 10]. Our 
blastn search among genome sequences of non‐baumannii 
ACB species deposited in the NCBI database identified other 
V1(lct) alleles among a few strains/isolates including A. pittii 
XJ88, A. pittii 2012N08‐034, A. lactucae CI78 and A. oleivorans 
DR1 sub‐species DE0008 (Table S2). Concerning the occur-
rence of V1(sct) alleles displaying the QQAQ short- terminal 
tract, only two alleles were found in a small percentage (0.53 
%) of A. baumannii strains/isolates (Tables 1 and S2). More 
divergent V1(sct) alleles were also identified among various 
non‐baumannii ACB species including strains of A. pittii, 
A. nosocomialis and A. seifertii (Table S2).
V2(lct) was the second most frequent OmpA variant found 
in A. baumannii, being present in almost 18 % of the strains/
isolates analysed (Table 1). Six different V2(lct) gene alleles 
were detected in A. baumannii differing in a maximum of two 
nucleotide substitutions translated to two V2 OmpA proteins 
displaying one amino acid substitution between them (Table 
S2). Other and more divergent V2(lct) alleles were detected 
also in a limited number of non‐baumannii ACB species, 
including A. calcoaceticus ANC3811 and A. oleivorans strains 
KCJK7897 and TUM15571 (Table S2).
The OmpA V3 group had a much lower representation 
(2.1 %) in A. baumannii (Table 1), with all strains/isolates 
displaying a V3(sct) ‘short’ QQAQ C‐terminal sequence 
type (Tables S1 and S2). Other more divergent V3(sct) 
alleles were detected among various non- baumannii ACB 
species including different A. nosocomialis, A. calcoaceticus 
and A. pittii strains (Table S2). Notably, we also detected the 
presence of a subgroup of V3 alleles carrying the (longer) 
QEAAAPAAAQ C‐terminal tract [designated V3(lct)] among 
a number of non- baumannii ACB species including the 
A. oleivorans type strain DR1 sub‐species DR1 (https://www. 
ncbi. nlm. nih. gov/ biosample/ SAMN02603211) and different 
strains of A. pittii, A. calcoaceticus and A. lactucae including 
the A. lactucae type strain NRRLB‐41902 (https://www. ncbi. 
nlm. nih. gov/ biosample/ SAMN04437545).
The OmpA V4 group also had a low representation in 
A. baumannii (2.6 %, Tables  1, S1 and S2). Most strains/
isolates carried the V4(lct) subgroup of alleles, which was 
composed of seven alleles differing by a maximum of 13 
nucleotide substitutions translated to four proteins differing 
in a maximum of two amino acid substitutions (Table S2). A 
V4(sct)sub‐group of alleles displaying the (shorter) QQAQ 
C‐terminal end was also found in two of the A. baumannii 
strains/isolates including the environmental DSM30011 
strain isolated before 1944 from a desert plant source [54]. 
Remarkably, our blastn search failed to detect V4 alleles 
among non‐baumannii ACB species.
Finally, V5 also had a very low representation in A. baumannii 
(0.53 %), with only five strains all showing the same V5(sct)
a1 allele (Tables  1 and S2). Among non‐baumannii ACB 
species V5(sct) alleles were also detected among a number 
of A. pittii strains that included the type strain ATCC 19004 
(https://www. ncbi. nlm. nih. gov/ biosample/ SAMN01828154) 
(Table S2). Notably also, a V5(lct) subvariant displaying 
QEAAAPAAAQ as the C‐terminal tract was also detected in 
the A. pittii strain WCHAP005046 (Table S2).
A. baumannii ompA polymorphism
A Shannon- entropy plot of all aligned A. baumannii OmpA 
variant alleles (Fig.  2a) showed that approximately 60 
from a total of almost 357 amino acid positions (17 %) are 
polymorphic. This polymorphism was concentrated in five 
well‐defined regions, four of them overlapping with the four 
extracellular loops located at the N‐terminal domain (EL1–
EL4) and the fifth at the C‐terminal end (Fig. 2a). Amino acid 
(Fig. 2a) and nucleotide (Fig. 2b) alignments show that the 
differences in length among variants are due to indels located 
in EL1, EL2 and EL3, and in the C‐terminal end.
Selection acting on ompA V1(lct) alleles
V1(lct) ompA was by far the most frequent variant found in 
A. baumannii, it encompassed the largest number of different 
alleles (Table 1), and was also found among non‐baumannii 
ACB species including strains of A. pittii, A. lactucae and 
A. oleivorans (Table S2). The large differences in frequency 
between the different V1(lct) alleles and the predominance 
of V1(lct)a1 (Table S2) led us to examine in more detail the 
nature of the changes occurring both within A. baumannii 
(intra‐species changes), and also between A. baumannii and 
non- baumannii (inter‐species changes) (Table  2, Fig. S3). 
Within A. baumannii V1(lct) alleles (intra‐species changes) 
the total number of synonymous substitutions was around 
3.85‐fold higher than that of non‐synonymous ones, with five 
out of the seven non‐synonymous substitutions concentrated 
in the EL‐coding regions (Table 2). A comparative analysis of 
the substitution patterns in the EL‐coding regions compared 
to the rest of the gene confirmed the different molecular 
evolutionary histories between the two (Table S4). Although 
there was a bias towards the EL regions carrying non‐synony-
mous substitutions, a detailed analysis of the resulting amino 
acid changes indicated that they represented conservative 
substitutions (Fig. S3). Similar conservative changes at the 
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Table 2. Summary of synonymous and non‐synonymous substitutions at polymorphic sites detected between V1(lct) ompA alleles found in strains/
isolates of the A. baumannii population analysed. The 1071 nucleotide positions encompassing 356 codons of the different V1(lct) ompA alleles 
described in this work were aligned, and the mutations resulting in synonymous (syn) and non‐synonymous (non‐syn) changes were calculated. The 
numbers between brackets denote the corresponding percentages among the 356 codons in each case
Gene regions Total changes Synonymous changes % syn Non- synonymous 
changes
% non- syn
Polymorphic sites found between the 32 A. baumannii V1(lct) alleles
All 34 (9.55) 27 (7.58) 79.4 7 (1.97) 20.6
EL regions 15 (4.21) 10 (2.81) 29.4 5 (1.40) 14.7
Non‐exposed regions (total) 19 (5.34) 17 (4.76) 50 2 (0.56) 5.9
TM regions only 9 (2.53) 9 (2.53) 33.3 0 0
EL regions were also observed inter‐species by comparing 
A. baumannii V1(lct)a1 with the V1(lct) alleles found in A. 
pittii, A. lactucae or A. oleivorans (Fig. S3). The overall results 
indicated a strong pressure operating both intra‐ and inter‐
species for the maintenance of the V1(lct) OmpA protein 
structure, including its exposed EL regions. Still, the large 
predominance of V1(lct)a1 among other V1(lct) alleles (Table 
S2, see above) argue against all amino acid substitutions accu-
mulating in this allele as completely lacking adaptive signifi-
cance. In this context, a comparative analysis of all changes 
detected (Fig. S3) identified a combination of two amino acid 
substitutions unique to V1(lct)a1. This combination resulted 
in the presence of two particular amino acid residues in the 
exposed regions of the protein, namely Ser52 at EL1 and 
Thr144 at EL3. It is tempting to speculate that the selective 
advantage provided by this combination represented the basis 
of the large predominance of V1(lct)a1 in A. baumannii.
Intra-genic recombination at the ompA locus
Detailed comparative analyses of the amino acid and corre-
sponding nucleotide sequences spanning the A. baumannii 
OmpA variant’s variable regions (Fig. 2b) suggested a history 
of intra‐genic recombination. The use of RDP4 (46) found 
evidence for intra‐genic recombinatorial exchanges between 
a number of alleles from various different V groups (Table S7). 
Visual inspection additionally detected substantial sequence 
identity between V4 and V5 along the entire EL2 and between 
V2 and V4 along EL4 (Fig. 2b). These observations are sugges-
tive of several intra‐genic recombinatorial exchanges during 
the early stages of evolution of the different ompA variants.
Intra‐genic recombination may also explain the existence of 
two alternate C‐terminal ends among otherwise very similar 
OmpA variants (see above). The main difference between 
sub‐ variants resides in the presence/absence of a hydrophobic 
tract of six amino acids, composed mostly by alanine residues, 
close to their C‐terminal ends (Fig. 2b, Table S3). We noted 
that the DNA sequence coding this tract, 5′‐GCGGCAGCTC-
CTGCAGCA‐3′, shows a higher GC content (72%) when 
compared to the rest of the A. baumannii ompA gene (42%) 
or even to the average GC content of Acinetobacter genomes 
[1–5, 7]. This suggests that the longer QEAAAPAAAQ C‐
terminal region may have derived from a non‐homologous 
(illegitimate) recombination event involving the insertion of 
a fragment originating in a high‐GC DNA source outside the 
Acinetobacter genus [55–58]. Moreover, this event is likely to 
have been selected recently in A. baumannii (or in a related 
ACB complex species), as judged by the presence of OmpAs 
bearing QEAAAPAAAQ as C‐terminal ends only among 
ACB members but not the other ecologically differentiated 
clades (Table S3) that compose the Acinetobacter genus [1].
We analysed possible donor(s) of the 18‐nucleotide high‐GC 
fragment among GenBank bacterial genomes by conducting 
a blastn search adjusted for short sequences identifica-
tion (https:// blast. ncbi. nlm. nih. gov). Among Acinetobacter 
sequences this stretch was found only in genomes of 
A. baumannii and some other ACB species, always inserted at 
the same position near the 3′‐end of the ompA gene (Fig. 2a, 
Table S3). Remarkably however, identical or highly similar 
sequences (17 out of 18 nucleotides identity), which were not 
linked to ompA/oprF‐related genes, were also found in the 
genomes of several bacterial species displaying GC contents 
≥60 % and assigned to different phyla including the Actino-
bacteria, the Bacteroidetes, and different subdivisions of the 
Proteobacteria (Table S5). Of note, the above taxa provide not 
only for the predominant micro- organisms in soils but also 
for the bacterial community associated with hand palms in 
humans [59]. These interconnecting niches, also shared by 
Moraxellaceae members including A. baumannii and other 
ACB species [1, 59], comprise a gene exchange community 
from which the above high‐GC fragment may have been 
acquired by A. baumannii (or by other ACB member) ompA 
by illegitimate recombination [56–58]. The presence of iden-
tical high‐GC stretches at similar gene positions in different 
A. baumannii ompA variants/subvariants (Fig. 2a) not only 
supports the notion that the further dissemination of this 
particular fragment among them proceeded by lateral gene 
transfer and fine‐scale homologous recombination [55], but 
also that it confers some fitness advantage(s) in the human‐
associated niches in which A. baumannii and other ACB 
species thrive [1].
Intra- and inter-species exchange of ompA variants
We investigated the possibility of ompA exchange within 
different lineages of the A. baumannii population (intra‐species 
8
Viale and Evans, Microbial Genomics 2020;6
Fig. 3. Evolutionary relatedness and ompA alleles of the Acinetobacter strains analysed in this work. An approximately ML core gene 
phylogeny was constructed using 474 core genes (present in ≥99 % of strains) with the non‐baumannii strain names coloured by species, 
as shown in the key. The tree is shown without scaling so that the relationships between strains can be seen, and is rooted on the branch 
separating the A. baumannii strains from the other Acinetobacter ACB species. The ompA gene alleles are indicated by the two rings of 
shapes surrounding the tree. The inner ring of shapes indicate the major V‐group that the ompA allele belongs to, and the outer ring 
indicates the specific gene allele. The two outermost circles indicate the MLST ST (inner circle) and CC (outer circle) according to the 
Pasteur MLST scheme, and the CCs are labelled (see Table S1 for details). Branches on the tree are coloured with respect to CC or ST.
recombination) and also between different ACB species (inter‐
species recombination). The overall observations are summa-
rized in Fig. 3 (see also Tables S1 and S2 for further details). 
In agreement with other studies using different sets of core 
genes and phylogenetic strategies [1, 2, 9, 54, 60] the cluster 
formed by A. baumannii strains/isolates was clearly demar-
cated in the ML tree from those composed of its phylogeneti-
cally closely related ACB species including A. nosocomialis, 
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A. seifertii, A calcoaceticus, A. oleivorans, A. lactucae and A. 
pittii, which were in turn well‐differentiated between them. 
The only exception was strain ANC3811, which has been 
assigned to A. calcoaceticus in the NCBI database (https://
www. ncbi. nlm. nih. gov/ genome/ 2267? genome_ assembly_ id= 
172286). In our ML analysis (Fig. 3) ANC3811 clustered with 
A. oleivorans strains, although as an outgroup of the other 
A. oleivorans strains employed. It is noteworthy in this context 
that ANC3811 contains an ompA V2(lct) allele similarly to 
A. oleivorans KCJK7897 and TUM15571 (Fig. 3), and that we 
could not detect V2(lct) genes among other A. calcoaceticus 
genome sequences deposited in the NCBI database (data not 
shown). Given the high similarity between A. calcoaceticus 
and A. oleivorans at the genome level [61], ANC3811 may 
thus well represent a taxonomic outlier close to both of these 
two species but not strictly belonging to either of them.
Several inferences could be derived from the analysis 
shown in Fig.  3. First, the A. baumannii strains/isolates 
comprising the major clonal complexes (as defined by the 
Institut Pasteur MLST scheme of population structure 
analysis, ref. 9): CC1, CC2 and CC3, as well as other CCs 
and STs of lower representation, formed well‐differentiated 
sub‐clusters in the ML tree of Fig. 3.These CCs are estimated 
to have evolved after 1960 from the clonal expansion each 
of a highly adaptive independent genotype, and they are 
generally thought to represent adaptations to specific micro-
niches and be robust with respect to gene choice [4, 5, 8–10]. 
Second, ompA V1(lct) alleles were found widely distributed 
among the different branches of the A. baumannii cluster, 
with the exception of a few CC lineages (see below). This, 
added to the elevated frequency of V1(lct) alleles in the 
A. baumannii clinical population analysed (Table  1) and 
their presence already in the clinical strains ATCC 17978 and 
ATCC 19606 (see above) supports the notion that V1(lct) 
alleles may not only represent important determinants in 
the interaction of A. baumannii with the human host, but 
also may have even predated the founding genotypes of 
the different CCs. Third, the distribution of ompA variants 
between different A. baumannii sub‐clusters (Fig. 3, Table 
S1) revealed non‐random associations of particular variants 
(or variant alleles) and certain CCs, and which have been 
summarized in Table 3. For instance, 96 % of the 502 CC2 
strains/isolates analysed displayed the ompA V1(lct)a1 allele 
(Table 3). From the two other V1(lct) alleles found among 
CC2 isolates (Fig.  3), V1(lct)a2 (two isolates) encodes an 
OmpA protein identical to V1(lct)a1, and V1(lct)a3 (16 
isolates) encodes a protein differing by a single conservative 
amino acid substitution located in the periplasmic domain 
(Table S2 and Figure S3). These observations indicated a 
strong pressure for the preservation of the protein sequence 
codified by V1(lct)a1 (or, more precisely, of its exposed EL 
regions) during the global dissemination/expansion of CC2. 
In addition, V1(lct)a1 was found in two other A. baumannii 
strains/isolates branching separately from the CC2 cluster: 
AB_2007‐09‐110‐01‐7 and NIPH70 (Fig. 3). This addition-
ally suggests that their acquisition by these two strains was 
mediated by recombinatorial ompA exchanges in which the 
donor probably belonged to CC2. It is also worth noting 
that in the CC2 subtree the isolates carrying V1(lct)a3 are 
interspaced among V1(lct)a1‐possessing isolates rather than 
grouped in a single cluster (Fig. 3), as it would be expected if 
they would have evolved clonally from a common ancestor. 
The observations above thus indicate not only the existence 
of exchanges of ompA genes between CC2 strains and other 
A. baumannii lineages, but also within CC2 as well. Fourth, 
the majority of the CC1 strains/isolates analysed (67 out of 
73, 91.8 %) displayed V2(lct)a1 (Fig.  3, Tables  3 and S1). 
Moreover, CC1 strains/isolates belonging to the main (L1) 
sublineage of this global clone, estimated to have separated 
from the CC1 founding genotype early during the 1970s 
[10], all displayed V2(lct)a1. This indicates that V2(lct)a1 
was strongly preserved during the global dissemination of 
this CC1 sub‐lineage. Three other CC1 strains, in this case 
assigned to the L2 sub‐lineage [9] (Fig. 3), showed V2(lct)
a6 differing from V2(lct)a1 by one amino acid substitution 
at EL2 (Table S2). It follows that V2(lct), and in particular 
V2(lct)a1, represents the predominant ompA variant associ-
ated with CC1. Still, three CC1 strains/isolates also belonging 
to the L2 sub‐lineage of CC1 showed instead V1(lct)a14 
(Fig. 3). This supports the idea of complete ompA variant 
replacements occurring very early during CC1 evolution, 
and which may have contributed to a better adaptation 
of this lineage to the human host or the nosocomial envi-
ronment. Fifth, strong links could be observed for other 
A. baumannii clonal lineages with particular ompA alleles, 
as is the case of ST3 and its phylogenetically related CC500 
lineage with V2(lct)a1; CC416 also with V2(lct)a1; ST406 
with V2(lct)a2; ST499 with V1(lct)a30; CC10 with V1(lct)
a27; CC79 with V1(lct)a5, CC15 with V1(lct)a8, ST49 with 
V4(lct)a1, ST52 with V1(lct)a14, etc. (Fig. 3, Table 3). The 
association of ST52 strains including ATCC 19606 (described 
in 1948) and more contemporary isolates with V1(lct)a14 
(Table S1) merits comment, since it indicates that this allele 
accompanied this lineage since at least 10 years before the 
estimated emergence of the major epidemic A. baumannii 
clonal complexes [8, 9]. Sixth, other A. baumannii clonal 
lineages on the contrary seemed less selective in their choice 
of ompA variants, including CC25 encompassing V1(lct)
a8‐, V1(lct)a5‐, V2(lct)a1‐ and V3(sct)a1‐carrying isolates; 
CC497 carrying V1(sct)a1, V1(lct)a1 and V5(sct)a1; ST16 
carrying different V4(sct) alleles (Fig. 3, Table 3). Among 
these examples, ST32 contained isolates carrying different 
V1(lct) alleles but that translated to identical proteins, and the 
same situation occurred with CC240 and CC821 (Table 3). 
These latter cases thus represent examples of different ompA 
gene allele exchanges but in which identical OmpA proteins 
were maintained (Table 3). The overall observations above 
disclosed the existence of frequent assortative exchanges of 
ompA genes in the A. baumannii population.
Evidence for ompA exchanges between A. baumannii and 
non‐baumannii ACB species could also be inferred from 
the analysis shown in Fig.  3. For instance, V1(lct) alleles 
were detected among A. pittii, A. lactucae and A. oleivorans 
strains, V1(sct) alleles among A. pittii, A. nosocomialis and 
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CC2 Among 502 CC2 isolates (474 ST2, 27 SLV, 1 DLV), 484 (96.4 %) carried V1(lct)a1; 2 (0.4 %) V2(lct)a2; and 16 (3.2 %) V1(lct)a3. CC2 thus contained 
99.6 % (484/486) of all V1(lct)a1‐carrying isolates found in the A. baumannii population analysed. Only V1(lct)a1 was found in two other isolates 
branching separately from the CC2 cluster: AB_2007‐09‐110‐01‐7 and NIPH70, providing evidences of V1(lct) exchanges between CC2 and other 
lineages.
CC1 Among 73 CC1 isolates (60 ST1, 12 SLV, 1 DLV), 67 (91.8 %) carried V2(lct)a1 (91.8 %); 3 V2(lct)a6 (4.1 %); and other 3 V1(lct)a14 (4.1 %). CC1 thus 
contained 45.6 % (67/147) of all V2(lct)a1‐carrying isolates found in the A. baumannii population analyzed. In addition, all isolates assigned to the 
main L1 sublineage of CC1 carried V2(lct)a1, the few detected V2(lct)a6‐ and V1(lct)a14‐containing isolates were restricted to the L2 sublineage. 
Evidences of exchanges of different variants and variant alleles during the evolution of this global clone.
ST3 All eight ST3 isolates carried V2(lct)a1. ST3 contained 5.4 % (8/147) of all V2(lct)a1‐carrying isolates found in the A. baumannii population analysed.
CC500 All 14 CC500 (13 ST500, 1 SLV) carried V2(lct)a1. CC500 contained 9.5 % of all V2(lct)a1‐carrying isolates found in the A. baumannii population. 
This CC lineage is phylogenetically close to ST3.
CC416 All 30 CC416 isolates (13 ST416, 17 SLV) carried V2(lct)a1. CC416 contained 20.4 % of all V2(lct)a1‐carrying isolates found in the A. baumannii 
population analysed.
CC417 All 19 CC417 isolates (14 ST417, 3 SLV, 2 DLV) carried V2(lct)a1. CC417 contained 12.9 % of all V2(lct)a1‐carrying isolates found in the A. 
baumannii population analysed.
CC79 All 20 CC79 isolates (9 ST79, 11 SLV) carried V1(lct)a5. CC79 thus contained 90.9 % (20/22) of all V1(lct)a5‐carrying isolates found in the A. 
baumannii population analysed.
CC10 All 48 CC10 strains (43 ST10, 5 SLV) carried V1(lct)a27. CC10 thus contained 98 % (48/49) of all V1(lct)a27‐carrying isolates found in the A. 
baumannii population analysed.
CC15 All seven CC15 isolates (six ST15, one SLV) carried V1(lct)a8. CC15 contained 16.3 % (7/43) of all V1(lct)a8‐carrying isolates found in the A. 
baumannii population.
ST406 All nine ST406 isolates carried V2(lct)a2. Thus, ST406 contained all V2(lct)a2‐carrying isolates found in the A. baumannii population.
ST499 All 20 ST499 isolates carried V1(lct)a30. Thus, ST499 contained all V1(lct)a30‐carrying isolates found in the A. baumannii population.
CC52 Composed by four ST52 isolates all carrying V1(lct)a14, isolated worldwide during a time period spanning 66 years: ATCCT19606 (USA, 1948), 
MSP4‐16 (India, 2010), GTC 03324 and GTC 03329 (Japan, 2014). CC52 includes another SLV isolate, AB_TG19617, carrying V1(lct)a6.
ST49 All four ST49 isolates carried V4(lct)a1 alleles. ST49 thus contained 44.4 % (4/9) of all V4(lct)a1 isolates found in the A. baumannii population.
CC25 The 47 CC25 isolates carried different ompA variants: 2 (ST25) carried V1(lct)a5, 31 (21 ST25, 10 SLV) carried V1(lct)a8, 4 (ST25) carried V2(lct)a1, 
and 10 (8 ST25, 1 SLV, 1 DLV) carried V3(sct)a1. Evidence of exchanges of different ompA variants and variant alleles.
ST16 The eight ST16 isolates analyzed carried different V4(lct) alleles: 5 carried V4(lct)a1 (55.5 % of all V4(lct)a1 alleles), 2 carried V4(lct)a4, and one 
carried V4(lct)a7. Evidence of different V4(lct) allele exchanges.
CC497 The six CC497 isolates carried different variants: Naval‐82 (SLV), TG27391 (SLV), 1 106 579 (SLV) and 83 444 (DLV) carried V1(sct)a1; A200 (SLV) 
carried V5(sct)a1, and AB_2007‐09‐110‐01‐7 (DLV) carried V1(lct)a1. Evidence of different ompA variant exchanges.
CC516 The five CC516 isolates carried different variants: AB405E4 (ST516) and CR‐ D1 (SLV) carried V1(lct)a32, A9 (DLV) carried V1(sct)a1, NIPH 80 
(DLV) and 1 440 422 (DLV) carried V1(lct)a14. Evidence of different variant and variant allele exchanges.
CC33 The three CC33 isolates carried different variants: NIPH615 (DLV) and A219 (SLV) both carried V1(lct)a24, TG02017 (ST33) carried V1(sct)a2. 
Evidences of ompA variant exchanges.
ST32 ST32 encompassed six isolates carrying different V1(lct) alleles: OIFC032, OIFC087, and OIFC099 carried V1(lct)a12, while 781 407, 1 525 283 and 
A147 displayed V1(lct)a13. The two V1(lct) alleles translate to identical proteins: G52S replacement as compared to V1(lct)a1. Evidence of V1(lct) 
allele exchange while maintaining the same OmpA characteristics.
CC216 This CC encompassed ten isolates: WC‐A‐92 (DLV); A185, A181, A134 and A173, (all four ST216) bearing V1(lct)a11; AB405E4 (DLV) bearing 
V1(lct)a32; A9 (ST216) containing V1(sct)a1; NCIMB8209 (SLV) containing V1(lct)a32; NIPH80 (DLV) and 1 440 422 (SLV) carrying V1(lct)a14. 
Evidence of ompA variant exchanges.
CC240 CC240 encompassed two avian isolates carrying different V1(lct) alleles: 01D3‐2 (ST240) carried V1(lct)a10 while 86II/2C (DLV) carried V1(lct)a16. 
All alleles translate to identical proteins: G52S replacement as compared to V1(lct)a1. Evidence of V1(lct) allele replacement while maintaining the 
OmpA protein characteristics.
CC821 CC821 encompassed four isolates, including three avian isolates carrying V1(lct)a14: LoGest3‐1 (ST821), 151/C (SLV), and Ganse Ei‐1 (DLV); 
and the clinical isolate A166B (SLV) displaying V1(lct)a10. Both alleles translate to the same protein: G52S replacement as compared to V1(lct)a1. 
Evidence of V1(lct) allele replacement while maintaining the same OmpA protein characteristics.
11
Viale and Evans, Microbial Genomics 2020;6
A. seifertii strains, V2(lct) alleles among A. oleivorans and 
A. calcoaceticus strains, V3(sct) alleles among A. nosocomialis, 
A. calcoaceticus and A. pittii strains, and V5(sct) alleles among 
A. pittii strains (Fig. 3). It is also noteworthy that V4(lct) and 
V4(sct) alleles were found only in A. baumannii but not 
among non‐baumannii strains and, conversely, that V3(lct) 
and V5(lct) alleles were found only among non‐baumannii 
strains (Table S2). The latter may reflect differential role(s) of 
these OmpA variants in the occupation of the various niches 
in which these ACB members thrive [1], although other 
factors could not be discarded at present (see below).
We also noted that the length of the OmpA signal peptide 
may vary between different ACB members, and even between 
different OmpA variants (Table S3). Thus, A. baumannii 
pre‐OmpAs, regardless of the variant considered, always 
showed identical signal peptides of 22 amino acid residues. 
Also, and in spite of the non‐baumannii ACB species analysed 
(A. nosocomialis, A. lactucae, A. oleivorans, A. seifertii or 
A. pittii), V1(lct) and V1(sct) pre‐OmpAs always showed 
signal peptides also of 22 amino acid residues (Table S3). On 
the other hand, and with the notorious exception of A. noso-
comialis WC‐487 V3(sct), all other OmpA variants present 
in non‐baumannii species showed identical transit peptides 
of a length of 21 amino acid residues (Table S3). In E. coli 
OmpA, mutations in the signal peptide can significantly 
alter the rate of precursor synthesis with dramatic effects on 
protein export and assembly in the OM and consequent cell 
toxicity [62]. OmpA variants represent the most abundant 
proteins in the OM of Acinetobacter species [3–6], and it 
is thus possible that the lengths of their signal peptides are 
subject of strong selection to obtain the most efficient export 
and assembly at the lowest cell cost. This compromise may 
also be extended not only to the particular OmpA variant 
considered, but also on the Acinetobacter species in which 
it is produced. Although this situation could in principle 
hinder successful exchanges of ompA variants between ACB 
species, this seems not to represent a critical limitation as 
judged by the presence of V2 alleles in A. baumannii and 
also in A. oleivorans and A. calcoaceticus; V3(sct) alleles in 
A. baumannii, A. nosocomialis, A. calcoaceticus and A. pittii; 
and V5(sct) alleles in A. baumannii and also in A. pittii (Fig. 3, 
Table S2). These exchanges certainly required the preservation 
of the ompA signal peptide coding region originally present 
in the recipient organism, and provide further evidence of 
fine‐scale intragenic recombination operating at the level of 
the Acinetobacter ompA locus.
DISCuSSIon
The study of A. baumannii ompA microevolution conducted 
here provides clues on the extent to which selection in the clin-
ical habitat has shaped evolution of this OmpA/OprF family 
member. We detected five well‐defined polymorphic OmpA 
variants in the A. baumannii population studied, primarily of 
clinical origin, with most of the variation occurring within the 
four exposed EL regions located at the N‐terminal β‐barrel 
domain of these proteins, and another in their C‐terminal 
region (Fig. 2). Our analyses here indicated that recombina-
tion, both assortative and fine‐scale, appeared as a significant 
agent driving evolution of A. baumannii OmpA variants. We 
found signs of different fine‐scale intra‐genic recombina-
tion among variants, some encompassing the EL regions 
which appeared to have occurred during their early stages 
of divergence from a recent common ancestor. Other events, 
which appear more subtle and more recent, result in different 
C‐terminal sequences in their otherwise highly conserved C‐
terminal periplasmic domains (Fig. 2, Table S3). The existence 
of two alternate C‐terminal ends differing in an Ala‐rich tract 
not only among different OmpA variants but also within a 
given variant, as in the case of V1 and V4 in A. baumannii 
(Fig. 2), strongly points to fine‐scale homologous recombina-
tion affecting the conserved ompA gene 3′‐region as the likely 
cause of this variability. Our analysis additionally suggested 
that the high‐GC DNA fragment encoding this Ala‐rich 
tract represents a relatively recent acquisition resulting from 
illegitimate recombination occurring in an A. baumannii (or 
a closely related ACB species) member adapting to human‐
associated environments. It is worth noting that OmpA vari-
ants bearing this C‐terminal Ala‐rich tract are found in 98 % 
of all strains/isolates of the A. baumannii population analysed 
(Table 1). Acinetobacter members can incorporate into their 
genomes short fragments of DNA taken from different 
sources, including the soil microcosms, by homologous or 
non‐homologous recombination processes [56–58]. In fact, 
natural transformation with highly fragmented (≥20 bp) and 
even partially damaged DNA has been shown to be much 
more efficient than spontaneous mutation to generate adja-
cent nucleotide polymorphism in their genomes [58]. The 
OmpA periplasmic domain contributes to the stability of the 
cell envelope by interacting non‐covalently with the pepti-
doglycan [28, 41] (Fig. S1), and its deletion in A. baumannii 
ATCC 17978 [ST437; V1(lct)a19 ompA; Fig. 3] has been found 
to result in an increased cell susceptibility to different antimi-
crobials including cell- wall synthesis inhibitors [63]. Also, in 
the carbapenem‐resistant A. baumannii strain AB5075 [ST1; 
V2(lct)a1 ompA; Fig. 3] the OmpA periplasmic domain has 
been found to associate with different OM and periplasmic 
proteins including an acquired OXA‐23 β‐lactamase [37]. Ala 
residues in proteins are strong promoters of the formation of 
α‐helices with strong propensity to insert in lipid membranes 
and adopt higher‐order structures stabilized by lateral, helix–
helix interactions [64]. The insertion of the hydrophobic Ala 
tract at the OmpA C‐terminal end may have resulted in an 
increased envelope stability towards the various cell- wall‐
damaging substances used in the nosocomial environment 
[30, 63, 65], thus providing the driving force for its selection 
during adaptation of A. baumannii to this particular niche.
The different OmpA variants were unequally distributed 
among the A. baumannii population, with V1(lct) alleles 
being found in around 76 % of the strains/isolates analysed 
and V2 alleles in around 18 % of them (Table 1). We also 
found a strong pressure for the preservation of alleles of 
these two variants during the dissemination and expansion 
of a number of A. baumannii clonal lineages, including the 
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main clonal complexes CC1, CC2 and CC3 (Fig. 3). Thus, 
V1(lct)a1 ompA was found primarily associated with CC2, 
while V2(lct)a1 was predominantly found among the main 
L1 lineage of CC1 and in CC3 (Fig. 3, Table 3). This suggests 
that the characteristics evolved by V1(lct)a1 OmpA confer 
significant fitness advantages to the strains that compose 
CC2, and the same applies for V2(lct)a1 OmpA in the case 
of CC2 and CC3. Strains composing other A. baumannii 
clonal lineages, in contrast, were apparently less selective 
in their use of ompA variants, as in the case of CC25 in 
which isolates carrying V1(lct)a5, V1(lct)a8, V2(lct)a1 and 
V3(sct)a1 were found (Fig. 3, Table 3). Even in this case, 
however, 33 out of the 47 CC25 strains (i.e., 70 %) carried 
V1(lct) alleles, with a great preponderance of V1(lct)a8 
(Table 3).
Significant genetic diversity is a hallmark of A. baumannii, 
even between phylogenetically closely related strains 
[3, 4, 7, 10, 12, 13]. Whole‐genome sequencing studies 
of CC2 and CC1 strains have indicated that most of this 
genomic diversity is driven by recombination, with genetic 
material derived from different A. baumannii strains co‐
existing in the environment [4, 10, 12, 13]. Many of these 
exchanges induced loss or swapping‐out of exposed struc-
tures potentially recognized by host defenses, such as the 
capsular polysaccharide, the outer core lipo‐oligosaccha-
ride, iron capture components, efflux pumps, replacements 
of the OM protein CarO by variant alleles, etc. [4, 10–13]. 
It is assumed that this process contributes to immune 
evasion, facilitating long‐term patient colonization and 
spread of the A. baumannii epidemic clones [10–13]. A. 
baumannii OmpA has been found capable of eliciting 
immune responses including the production of anti‐OmpA 
antibodies both in infected patients [19, 38] and experi-
mentally infected mice [16, 22]. It is then noteworthy 
that, in sharp contrast with the other surface‐exposed 
macromolecules mentioned above, particular ompA V1 
and V2 alleles have been strongly preserved during the 
dissemination and expansion of the major A. baumannii 
global clones CC1 and CC2. This preservation supports 
the notion that these two OmpA variants play pivotal roles 
in A. baumannii pathogenicity [3–7, 20, 21, 31–36]. Their 
escape from host defenses could result, at least in part, 
from the recently disclosed shielding by capsule polysac-
charide production during the course of A. baumannii 
infection [66]. The reasons for the success of CC strains as 
human pathogens are still poorly understood, and each CC 
appears in fact able to express a multiplicity of virulence 
factors in different combinations [3–6]. This has led to 
proposals that the virulence potential of strains composing 
the different CCs may reside on polymorphic differences 
in shared virulence genes and/or the combinatory effect 
of multiple genes [3–6]. OmpA is in fact a moonlighting 
protein implicated in a multitude of separate functions 
that include structural roles, slow porin for metabolites 
and antimicrobials, participation in virulence traits such 
as adhesion to extracellular matrix proteins, binding to 
host- cell receptors, biofilm formation and cytotoxicity 
[3–6, 19, 20, 29–36]. Thus, the functions of a particular 
OmpA variant in some epidemic A. baumannii lineages 
could be more related to the recognition of a specific host 
(or host tissue) and/or to the induction of cytotoxicity in 
a close interplay with other pathogenicity factors, and thus 
its exchange for another variant (or even a different allele) 
may be strongly selected against. In other A. baumannii CC 
lineages more prone to explore different niches, in contrast, 
OmpA may not be as highly demanded for pathogenicity 
and thus exchanges can be more frequently observed 
among its members. In any case, the observation made 
in this work that ompA variants, variant alleles, or even 
ompA gene sectors can be effectively exchanged by either 
assortative or fine‐scale recombination not only among 
different A. baumannii lineages but also between different 
ACB species represents a worrying scenario, providing that 
any innovation affecting host specificity or persistence may 
be rapidly disseminated among all components of this 
expanded community.
Finally, there has been interest in developing a vaccine 
against A. baumannii using OmpA as immunogen 
[16–22, 38]. However, the recombinatorial potential of 
ompA variants shown in this work may pose severe limi-
tations to the effectiveness of a vaccine based solely on 
a single OmpA variant. It remains to be tested whether 
polyvalent OmpA vaccines generated through directed 
protein evolution [67] using the analysis provided in 
this work could prevent infections due to A. baumannii 
strains bearing different ompA variants. Further investi-
gations involving functional studies of different OmpA 
variants/variant alleles may shed light upon the relative 
strengths of selection acting upon these OM proteins and 
help the development of new strategies for combating 
A. baumannii and other ACB infections.
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